Physician-Level Continuity of Care and Patient Outcomes in All-Payer Claims Database
© Copyright by the American Board of Family Medicine..
INTRODUCTION: Being one of the few existing measures of primary care functions, physician-level continuity of care (Phy-CoC) is measured by the weighted average of patient continuity scores. Compared with the well-researched patient-level continuity, Phy-CoC is a new instrument with limited evidence from Medicare beneficiaries. This study aimed to expand the patient sample to include patients of all ages and all types of insurance and reassess the associations between full panel-based Phy-CoC scores and patient outcomes.
METHODS: Cross-sectional analysis at patient-level using Virginia All-Payer Claims Database (VA-APCD). Phy-CoC scores were calculated by averaging patient's Bice-Boxerman Index scores and weighted by the total number of visits. Patient outcomes included total cost and preventable hospitalization.
RESULTS: In a sample of 1.6 million Virginians, patients who lived in rural areas or had Medicare as primary insurance were more likely to be attributed to physicians with the highest Phy-CoC scores. Across all adult patient populations, we found that being attributed to physicians with higher Phy-CoC was associated with 7%-11.8% higher total costs, but was not associated with the odds of preventable hospitalization. Results from models with interactions revealed nuanced associations between Phy-CoC and total cost with patient's age and comorbidity, insurance payer, and the specialty of their physician.
CONCLUSIONS: In this comprehensive examination of Phy-CoC using all populations from the VA-APCD, we found an overall positive association of higher full panel-based Phy-CoC with total cost, but a non-significant association with the risk of preventable hospitalization. Achieving higher full panel-based Phy-CoC may have unintended cost implications.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:36 |
|---|---|
| Enthalten in: |
Journal of the American Board of Family Medicine : JABFM - 36(2024), 6 vom: 05. Jan., Seite 976-985 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Dai, Mingliang [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Continuity of Care |
|---|
| Anmerkungen: |
Date Completed 08.01.2024 Date Revised 08.01.2024 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.3122/jabfm.2023.230119R1 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM366621971 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM366621971 | ||
| 003 | DE-627 | ||
| 005 | 20240114232125.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240108s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3122/jabfm.2023.230119R1 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1252.xml |
| 035 | |a (DE-627)NLM366621971 | ||
| 035 | |a (NLM)38171580 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Dai, Mingliang |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Physician-Level Continuity of Care and Patient Outcomes in All-Payer Claims Database |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.01.2024 | ||
| 500 | |a Date Revised 08.01.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © Copyright by the American Board of Family Medicine. | ||
| 520 | |a INTRODUCTION: Being one of the few existing measures of primary care functions, physician-level continuity of care (Phy-CoC) is measured by the weighted average of patient continuity scores. Compared with the well-researched patient-level continuity, Phy-CoC is a new instrument with limited evidence from Medicare beneficiaries. This study aimed to expand the patient sample to include patients of all ages and all types of insurance and reassess the associations between full panel-based Phy-CoC scores and patient outcomes | ||
| 520 | |a METHODS: Cross-sectional analysis at patient-level using Virginia All-Payer Claims Database (VA-APCD). Phy-CoC scores were calculated by averaging patient's Bice-Boxerman Index scores and weighted by the total number of visits. Patient outcomes included total cost and preventable hospitalization | ||
| 520 | |a RESULTS: In a sample of 1.6 million Virginians, patients who lived in rural areas or had Medicare as primary insurance were more likely to be attributed to physicians with the highest Phy-CoC scores. Across all adult patient populations, we found that being attributed to physicians with higher Phy-CoC was associated with 7%-11.8% higher total costs, but was not associated with the odds of preventable hospitalization. Results from models with interactions revealed nuanced associations between Phy-CoC and total cost with patient's age and comorbidity, insurance payer, and the specialty of their physician | ||
| 520 | |a CONCLUSIONS: In this comprehensive examination of Phy-CoC using all populations from the VA-APCD, we found an overall positive association of higher full panel-based Phy-CoC with total cost, but a non-significant association with the risk of preventable hospitalization. Achieving higher full panel-based Phy-CoC may have unintended cost implications | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Continuity of Care | |
| 650 | 4 | |a Cost | |
| 650 | 4 | |a Cross-Sectional Studies | |
| 650 | 4 | |a Medicare | |
| 650 | 4 | |a Physicians | |
| 650 | 4 | |a Primary Health Care | |
| 650 | 4 | |a Virginia | |
| 700 | 1 | |a Morgan, Zachary J |e verfasserin |4 aut | |
| 700 | 1 | |a Russel, Kyle |e verfasserin |4 aut | |
| 700 | 1 | |a Bortz, Beth A |e verfasserin |4 aut | |
| 700 | 1 | |a Peterson, Lars E |e verfasserin |4 aut | |
| 700 | 1 | |a Bazemore, Andrew W |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of the American Board of Family Medicine : JABFM |d 2006 |g 36(2024), 6 vom: 05. Jan., Seite 976-985 |w (DE-627)NLM160846994 |x 1558-7118 |7 nnns |
| 773 | 1 | 8 | |g volume:36 |g year:2024 |g number:6 |g day:05 |g month:01 |g pages:976-985 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3122/jabfm.2023.230119R1 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 36 |j 2024 |e 6 |b 05 |c 01 |h 976-985 | ||